Shares of Globus Medical, Inc. (NYSE: GMED - Get Free Report) have earned an average recommendation of "Moderate Buy" from the fourteen ratings firms that are covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Fisher Asset Management LLC lessened its stake in Globus Medical, Inc. (NYSE: GMED) by 12.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 288,073 shares of the medical device company's stock after selling 42,835 shares during the quarter. Fisher Asset Management LLC

Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.

Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?

American Century Companies Inc. boosted its holdings in shares of Globus Medical, Inc. (NYSE: GMED) by 123.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 298,221 shares of the medical device company's stock after buying an additional 164,813 shares during

December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.

Stocks like TTWO, GMED, ROK, CNQ and VICI stand out with strong sales growth expectations despite market uncertainty.